Flow-Cytometric Monitoring of Minimal Residual Disease in Pediatric Patients With Acute Myeloid Leukemia: Recent Advances and Future Strategies

• Asıl Yazarlar: Barbara Buldini (Yazar), Margarita Maurer-Granofszky (Yazar), Elena Varotto (Yazar), Michael N. Dworzak (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Minimal residual disease (MRD) by multiparametric flow cytometry (MFC) has been recently shown as a strong and independent prognostic marker of relapse in pediatric AML (pedAML) when measured at specific time points during Induction and/or Consolidation therapy. Hence, MFC-MRD has the potential to r...